Please login to the form below

Not currently logged in
Email:
Password:

pegaspargase

This page shows the latest pegaspargase news and features for those working in and with pharma, biotech and healthcare.

SMC approves Opdivo combo as first-line skin cancer treatment

SMC approves Opdivo combo as first-line skin cancer treatment

The regulator also accepted Baxalta's Oncaspar (pegaspargase) for NHS use, approving the drug as part of an antineoplastic combination therapy for paediatric and adult patients with acute lymphoblastic leukaemia.

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Deal Watch July 2016 Deal Watch July 2016

    Pfenex is a biosimilars company, and the agreement with Jazz also includes rights to a recombinant pegaspargase candidate.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics